SCHEMBL8062587

SCHEMBL8062587

C1CC2CNCCC2C[N]1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3116836 1.00 KCNH2 (0.30) KCNH2
SCHEMBL2379031 0.91 KCNH2 (0.30) KCNH2
SCHEMBL8044811 0.87 SLC6A1 (0.32)
SCHEMBL7588112 0.86 CHRNB2 (0.34)
SCHEMBL8044661 0.86
SCHEMBL1385525 0.83
SCHEMBL1383611 0.83
SCHEMBL8056815 0.78 SLC6A1 (0.32)
SCHEMBL13250365 0.77 CCR5 (0.47) KCNH2
SCHEMBL1243243 0.77 CCR5 (0.47) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed